Andrew Obenshain Bluebird Bio, Inc. (BLUE) insider trading activity

Andrew Obenshain is President and CEO of bluebird bio, Inc.. Currently has a direct ownership of 18,327 shares of BLUE, which is worth approximately $73,857. The most recent transaction as insider was on Apr 05, 2021, when has been sold 29 shares (Common Stock) at a price of $30.21 per share, resulting in proceeds of $876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.3K

0.85% 3M change

93.45% 12M change

Total Value Held $73,857

Andrew Obenshain Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 05 2021	SELL Open market or private sale	$876 $30.21 p/Share	29 Reduced 0.07%	40,137 Common Stock
Mar 02 2021	SELL Open market or private sale	$1,006 $29.58 p/Share	34 Reduced 0.08%	40,166 Common Stock
Feb 17 2021	SELL Open market or private sale	$21,092 $28.16 p/Share	749 Reduced 1.83%	40,200 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	17,065 Added 29.42%	40,949 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,562 $45.93 p/Share	34 Reduced 0.14%	23,884 Common Stock

Andrew Obenshain

President and CEO

Somerville, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE

Account